Total Payments
$2,941
2024 Payments
$458.48
Companies
30
Transactions
138
Medicare Patients
1,015
Medicare Billing
$278,905
Payment Breakdown by Category
Food & Beverage$2,843 (96.7%)
Education$98.46 (3.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,843 | 132 | 96.7% |
| Education | $98.46 | 6 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $409.06 | 25 | $0 (2023) |
| Minerva Surgical, Inc | $361.95 | 4 | $0 (2023) |
| Exeltis, USA Inc. | $329.66 | 18 | $0 (2024) |
| ABBVIE INC. | $306.98 | 13 | $0 (2023) |
| Organon Llc | $200.68 | 9 | $0 (2024) |
| Astellas Pharma US Inc | $194.37 | 8 | $0 (2024) |
| Novo Nordisk Inc | $143.86 | 9 | $0 (2023) |
| Hologic, LLC | $136.05 | 3 | $0 (2022) |
| AMAG Pharmaceuticals, Inc. | $126.51 | 7 | $0 (2019) |
| Amgen Inc. | $115.88 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $458.48 | 24 | Exeltis, USA Inc. ($164.73) |
| 2023 | $553.67 | 27 | Astellas Pharma US Inc ($147.88) |
| 2022 | $795.95 | 28 | Minerva Surgical, Inc ($169.13) |
| 2021 | $345.58 | 10 | Minerva Surgical, Inc ($166.16) |
| 2020 | $45.66 | 3 | AbbVie Inc. ($18.90) |
| 2019 | $193.54 | 14 | Bayer HealthCare Pharmaceuticals Inc. ($57.17) |
| 2018 | $276.75 | 14 | AbbVie, Inc. ($78.80) |
| 2017 | $271.54 | 18 | Bayer HealthCare Pharmaceuticals Inc. ($58.61) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: CONTRACEPTIVE | ||||||
| 12/13/2024 | Organon Llc | JADA SYSTEM (Device) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: POSTPARTUM UTERINE HEMORRHAGING | ||||||
| 12/07/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: WOMENS HEALTH | ||||||
| 11/15/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $24.53 | General |
| 11/13/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: CONTRACEPTIVE | ||||||
| 10/18/2024 | Organon Llc | JADA SYSTEM (Device) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: POSTPARTUM UTERINE HEMORRHAGING | ||||||
| 10/11/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: ETONOGESTREL | ||||||
| 09/27/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: CONTRACEPTIVE | ||||||
| 08/29/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: CONTRACEPTIVE | ||||||
| 08/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: UROLOGY | ||||||
| 07/22/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: CONTRACEPTIVE | ||||||
| 06/21/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: CONTRACEPTIVE | ||||||
| 06/12/2024 | Medtronic, Inc. | LIGASURE (Device) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Vessel Sealing | ||||||
| 06/07/2024 | Organon Llc | — | Food and Beverage | In-kind items and services | $21.24 | General |
| 05/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Bone Health | ||||||
| 05/17/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: CONTRACEPTIVE | ||||||
| 04/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Biological | ||||||
| 04/08/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Bone Health | ||||||
| 03/11/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: ETONOGESTREL | ||||||
| 03/09/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: CONTRACEPTIVE | ||||||
| 02/15/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Bone Health | ||||||
| 02/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Biological | ||||||
| 02/13/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: CONTRACEPTIVE | ||||||
| 02/02/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: ETONOGESTREL | ||||||
| 11/10/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 259 | 3,762 | $210,482 | $79,919 |
| 2022 | 6 | 239 | 3,438 | $192,228 | $67,792 |
| 2021 | 7 | 246 | 3,618 | $202,010 | $69,190 |
| 2020 | 8 | 271 | 3,448 | $189,339 | $62,005 |
Total Patients
1,015
Total Services
14,266
Medicare Billing
$278,905
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 35 | 3,480 | $153,120 | $63,676 | 41.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 108 | $19,008 | $6,631 | 34.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 75 | $19,500 | $5,985 | 30.7% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 16 | 19 | $8,493 | $1,655 | 19.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $5,523 | $1,421 | 25.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 36 | 59 | $4,838 | $550.72 | 11.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 34 | 3,180 | $139,920 | $53,501 | 38.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 74 | $19,240 | $5,949 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 83 | $14,608 | $4,696 | 32.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 28 | 28 | $7,364 | $2,080 | 28.2% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 14 | 14 | $6,258 | $940.95 | 15.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 33 | 59 | $4,838 | $624.85 | 12.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 34 | 3,360 | $147,840 | $54,137 | 36.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 84 | 84 | $21,840 | $6,653 | 30.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 56 | 80 | $14,026 | $4,854 | 34.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $4,400 | $1,118 | 25.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $3,419 | $975.91 | 28.5% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 13 | 13 | $5,811 | $818.24 | 14.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 35 | 57 | $4,674 | $633.60 | 13.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 35 | 3,180 | $139,920 | $49,268 | 35.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 95 | 95 | $24,700 | $6,232 | 25.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 57 | 71 | $12,496 | $3,490 | 27.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 11 | 11 | $2,893 | $895.29 | 30.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 15 | 15 | $2,295 | $656.48 | 28.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 35 | 53 | $4,346 | $614.39 | 14.1% |
About Dr. Christopher Keeley, MD
Dr. Christopher Keeley, MD is a Obstetrics & Gynecology healthcare provider based in Salem, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417914821.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Keeley, MD has received a total of $2,941 in payments from pharmaceutical and medical device companies, with $458.48 received in 2024. These payments were reported across 138 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($2,843).
As a Medicare-enrolled provider, Keeley has provided services to 1,015 Medicare beneficiaries, totaling 14,266 services with total Medicare billing of $278,905. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Salem, VA
- Active Since 04/28/2006
- Last Updated 02/09/2022
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1417914821
Products in Payments
- SLYND (Drug) $279.15
- LO LOESTRIN FE (Drug) $213.11
- Kyleena (Drug) $211.71
- Veozah (Drug) $182.49
- NEXPLANON (Drug) $175.19
- Mirena (Drug) $164.89
- ACESSA PROVU SYSTEM (Device) $124.54
- INTRAROSA (Drug) $113.99
- EVENITY (Biological) $97.44
- Saxenda (Drug) $89.89
- Lupron (Drug) $78.80
- Flexitouch Plus (Device) $56.18
- Solosec (Drug) $50.51
- JADA SYSTEM (Device) $46.07
- MYFEMBREE (Drug) $44.00
- PREMARIN (Drug) $39.80
- Global Endometrial Abiation (Device) $35.02
- IMVEXXY (Drug) $34.65
- Wegovy (Drug) $33.78
- CitraNatal (Drug) $25.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Salem
Joseph Troise, M.d, M.D
Obstetrics & Gynecology — Payments: $144,119
Obstetrics & Gynecology $144,119
Dr. Robert Harder, Md, MD
Obstetrics & Gynecology — Payments: $56,181
Obstetrics & Gynecology $56,181
John Harding, Md, MD
Obstetrics & Gynecology — Payments: $4,568
Obstetrics & Gynecology $4,568
Dr. Betsy August, Md, MD
Obstetrics & Gynecology — Payments: $4,273
Obstetrics & Gynecology $4,273
Laura Chong, M.d, M.D
Obstetrics & Gynecology — Payments: $3,647
Obstetrics & Gynecology $3,647
Dr. Joseph Stalfire, Md, MD
Obstetrics & Gynecology — Payments: $2,995
Obstetrics & Gynecology $2,995